Cardinal Capital Management Has $10.18 Million Stake in Agilent Technologies, Inc. (NYSE:A)

Cardinal Capital Management lifted its stake in Agilent Technologies, Inc. (NYSE:A) by 4.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 68,551 shares of the medical research company’s stock after purchasing an additional 2,665 shares during the period. Agilent Technologies accounts for 1.6% of Cardinal Capital Management’s portfolio, making the stock its 17th largest position. Cardinal Capital Management’s holdings in Agilent Technologies were worth $10,178,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently bought and sold shares of the stock. Quantbot Technologies LP acquired a new position in Agilent Technologies during the 1st quarter valued at about $938,000. Cetera Investment Advisers lifted its holdings in Agilent Technologies by 953.3% in the first quarter. Cetera Investment Advisers now owns 32,694 shares of the medical research company’s stock valued at $4,757,000 after buying an additional 29,590 shares during the period. iA Global Asset Management Inc. boosted its stake in Agilent Technologies by 26.2% in the first quarter. iA Global Asset Management Inc. now owns 21,770 shares of the medical research company’s stock valued at $3,168,000 after acquiring an additional 4,523 shares during the last quarter. Bayesian Capital Management LP acquired a new stake in Agilent Technologies during the 1st quarter worth $1,355,000. Finally, Nomura Holdings Inc. bought a new stake in shares of Agilent Technologies during the 4th quarter valued at $823,000. Institutional investors own 87.42% of the company’s stock.

Insider Transactions at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the transaction, the chief executive officer now directly owns 24,118 shares of the company’s stock, valued at approximately $3,497,110. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the transaction, the chief executive officer now owns 24,118 shares of the company’s stock, valued at $3,497,110. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the sale, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 13,953 shares of company stock worth $2,013,630 in the last 90 days. Corporate insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Wolfe Research cut Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research note on Thursday, June 27th. Stifel Nicolaus restated a “buy” rating and set a $151.00 target price on shares of Agilent Technologies in a research report on Monday, August 26th. Citigroup increased their price target on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. UBS Group boosted their price objective on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Finally, Bank of America upped their target price on shares of Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, five have given a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $144.36.

Agilent Technologies Price Performance

A stock opened at $137.42 on Friday. The stock has a 50-day moving average price of $140.98 and a two-hundred day moving average price of $138.85. Agilent Technologies, Inc. has a 1 year low of $96.80 and a 1 year high of $155.35. The stock has a market cap of $40.09 billion, a PE ratio of 32.49, a price-to-earnings-growth ratio of 6.96 and a beta of 1.05. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The firm’s revenue for the quarter was down 5.6% compared to the same quarter last year. During the same quarter last year, the firm earned $1.43 earnings per share. Equities analysts forecast that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st will be given a dividend of $0.236 per share. This represents a $0.94 annualized dividend and a dividend yield of 0.69%. The ex-dividend date is Tuesday, October 1st. Agilent Technologies’s dividend payout ratio (DPR) is 22.22%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.